IL285984A - A method for producing a split influenza component - Google Patents

A method for producing a split influenza component

Info

Publication number
IL285984A
IL285984A IL285984A IL28598421A IL285984A IL 285984 A IL285984 A IL 285984A IL 285984 A IL285984 A IL 285984A IL 28598421 A IL28598421 A IL 28598421A IL 285984 A IL285984 A IL 285984A
Authority
IL
Israel
Prior art keywords
split vaccine
producing influenza
influenza
producing
vaccine
Prior art date
Application number
IL285984A
Other languages
English (en)
Hebrew (he)
Original Assignee
Japan As Represented By Director General Of Nat Institute Of Infectious Diseases
Sumitomo Dainippon Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Japan As Represented By Director General Of Nat Institute Of Infectious Diseases, Sumitomo Dainippon Pharma Co Ltd filed Critical Japan As Represented By Director General Of Nat Institute Of Infectious Diseases
Publication of IL285984A publication Critical patent/IL285984A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/145—Orthomyxoviridae, e.g. influenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/543—Mucosal route intranasal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
    • A61K2039/575—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2 humoral response
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pulmonology (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Mycology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
IL285984A 2019-03-04 2021-08-31 A method for producing a split influenza component IL285984A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2019038662 2019-03-04
PCT/JP2020/008974 WO2020179797A1 (ja) 2019-03-04 2020-03-03 インフルエンザｈａスプリットワクチンの製造方法

Publications (1)

Publication Number Publication Date
IL285984A true IL285984A (en) 2021-10-31

Family

ID=72337458

Family Applications (1)

Application Number Title Priority Date Filing Date
IL285984A IL285984A (en) 2019-03-04 2021-08-31 A method for producing a split influenza component

Country Status (14)

Country Link
US (1) US20220152191A1 (en])
EP (1) EP3936147A4 (en])
JP (1) JP7545955B2 (en])
KR (1) KR20210135261A (en])
CN (1) CN114096273A (en])
AU (1) AU2020233456A1 (en])
BR (1) BR112021017310A8 (en])
CA (1) CA3132578A1 (en])
EA (1) EA202192398A1 (en])
IL (1) IL285984A (en])
MX (1) MX2021010685A (en])
PH (1) PH12021552094A1 (en])
SG (1) SG11202109566XA (en])
WO (1) WO2020179797A1 (en])

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2019311965A1 (en) 2018-07-23 2021-02-25 Japan As Represented By Director General Of National Institute Of Infectious Diseases Composition containing influenza vaccine
KR20220098370A (ko) * 2019-11-07 2022-07-12 세퀴러스 유케이 리미티드 감소된 입자 크기를 가지는 바이러스 백신을 제조하기 위한 조성물 및 방법
TW202506714A (zh) * 2023-04-26 2025-02-16 國立感染症研究所長代表之日本國 抗流感抗體

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2374894B1 (en) * 1993-09-13 2014-09-17 Protein Sciences Corporation A method for producing influenza hemagglutinin multivalent vaccines
US20230201329A1 (en) * 2006-07-17 2023-06-29 Glaxosmithkline Biologicals Sa Influenza vaccine
US20090181078A1 (en) * 2006-09-26 2009-07-16 Infectious Disease Research Institute Vaccine composition containing synthetic adjuvant
US9452209B2 (en) * 2007-04-20 2016-09-27 Glaxosmithkline Biologicals Sa Influenza vaccine
CN102223895B (zh) * 2008-11-25 2014-11-05 巴克斯特保健股份有限公司 生产pH稳定的包膜病毒的方法
CN102406931B (zh) * 2011-11-25 2014-02-05 成都康华生物制品有限公司 大流行流感病毒裂解疫苗
CN104302317B (zh) * 2012-05-16 2016-07-06 Kj生物科学有限公司 新型和改进的流感疫苗
KR20140118682A (ko) 2013-03-29 2014-10-08 (주)셀트리온 2 이상의 인플루엔자 ａ 바이러스 중화 결합 분자를 포함하는 조성물
JP2018517405A (ja) * 2015-05-04 2018-07-05 エピバックス インコーポレーテッド インフルエンザａ／上海／２／２０１３ ｈ７配列の改変ｈ７赤血球凝集素糖タンパク質
WO2017056494A1 (en) * 2015-09-29 2017-04-06 Sumitomo Dainippon Pharma Co., Ltd. Adenine conjugate compounds and their use as vaccine adjuvants
EP3603619B1 (en) * 2017-03-29 2025-08-13 Sumitomo Pharma Co., Ltd. Vaccine adjuvant formulation
JP7403733B2 (ja) * 2017-09-04 2023-12-25 国立感染症研究所長 インフルエンザｈａスプリットワクチンの製造方法
AU2019311965A1 (en) * 2018-07-23 2021-02-25 Japan As Represented By Director General Of National Institute Of Infectious Diseases Composition containing influenza vaccine
CN113194986A (zh) * 2018-12-26 2021-07-30 大日本住友制药株式会社 包括疫苗佐剂的制剂
CA3131551A1 (en) * 2019-02-28 2020-09-03 Novavax, Inc. Methods for preventing disease or disorder caused by rsv infection

Also Published As

Publication number Publication date
BR112021017310A2 (en]) 2021-11-16
KR20210135261A (ko) 2021-11-12
BR112021017310A8 (pt) 2022-12-06
SG11202109566XA (en) 2021-10-28
WO2020179797A1 (ja) 2020-09-10
MX2021010685A (es) 2021-12-10
EP3936147A1 (en) 2022-01-12
AU2020233456A1 (en) 2021-10-07
EA202192398A1 (ru) 2021-11-23
PH12021552094A1 (en) 2022-05-30
JP7545955B2 (ja) 2024-09-05
JPWO2020179797A1 (en]) 2020-09-10
US20220152191A1 (en) 2022-05-19
CA3132578A1 (en) 2020-09-10
EP3936147A4 (en) 2022-09-28
CN114096273A (zh) 2022-02-25

Similar Documents

Publication Publication Date Title
IL281220A (en) Process for preparing vaccine compositions
EP3256571A4 (en) Methods for producing virus for vaccine production
IL285984A (en) A method for producing a split influenza component
SG11201906984VA (en) Method for producing cyclododecanone
IL309408A (en) Multivalent flu vaccines
SG11201911164WA (en) Method for preparing intermediate of 4-methoxypyrrole derivative
EP3708567A4 (en) PROCESS FOR THE PREPARATION OF A BENZOFURANE DERIVATIVE
SG11202001937TA (en) Method for producing influenza ha split vaccine
EP3588654A4 (en) PROCESS FOR PRODUCING A MONOCELL
IL283331A (en) Method for the preparation of n-phenylpyrazole-1-carboxamides
EP3630722A4 (en) 4-METHOXYPYRROLE DERIVATIVE INTERMEDIATE PREPARATION PROCESS
EP3594217A4 (en) PROCESS FOR THE PRODUCTION OF DIALKYLAMINOSILANE
EP3402514A4 (en) METHOD AND COMPOSITIONS FOR INFLUENZA VACCINATION
EP3733858A4 (en) METHOD FOR PRODUCING UROLITHIN
GB202004825D0 (en) Influenza vaccines
EP3633078A4 (en) METHOD FOR MANUFACTURING A TITANIUM-COATED ELEMENT
SG11202108435WA (en) Method for virus production
PL3733651T3 (pl) Sposób wytwarzania kalkobutrolu
EP3543236A4 (en) PROCESS FOR THE PREPARATION OF AN AVIBACTAM INTERMEDIATE
EP3351534A4 (en) PROCESS FOR PREPARING A NOVEL 4-BENZAZONINE DERIVATIVE
GB201820751D0 (en) Methods for preparing intermediates
EP3689852A4 (en) DIHYDROXYINDOLS PRODUCTION PROCESS
IL311964A (en) Multivalent influenza vaccines
IL279070A (en) A method for the production of diarylpyridine derivatives
EP3763708A4 (en) METHOD OF MANUFACTURING CYCLIC ETHER